chr16-1229627-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024164.6(TPSB2):c.172T>C(p.Phe58Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,456,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F58I) has been classified as Uncertain significance.
Frequency
Consequence
NM_024164.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPSB2 | NM_024164.6 | c.172T>C | p.Phe58Leu | missense_variant | Exon 3 of 6 | ENST00000606293.5 | NP_077078.5 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 28
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1456566Hom.: 0 Cov.: 89 AF XY: 0.00000138 AC XY: 1AN XY: 724608 show subpopulations
GnomAD4 genome Cov.: 28
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at